Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-03-31

Clinical Trial Update: Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical study evaluating Ganoderma lucidum spore combined with chemotherapy for non-small cell lung cancer. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganoderma lucidum spore (Ganoderma lucidum spore extract)

Snippet

Sponsor: Gao Yajie | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN